High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia

被引:68
作者
Angeloni, A
Heston, L
Uccini, S
Sirianni, MC
Cottoni, F
Masala, MV
Cerimele, D
Lin, SF
Sun, R
Rigsby, M
Faggioni, A
Miller, G
机构
[1] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Biochem & Mol Biophys, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[5] Univ Rome La Sapienza, Dept Expt Med & Pathol, I-00185 Rome, Italy
[6] Univ Rome La Sapienza, Dept Clin Med, I-00185 Rome, Italy
[7] Univ Sassari, Dept Dermatol, I-07100 Sassari, Italy
[8] Dept Vet Affairs, Connecticut Healthcare Syst, W Haven, CT USA
关键词
D O I
10.1086/517429
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A survey for antibodies to a recombinant small viral capsid antigen (sVCA) of human herpesvirus type 8 (HHV-8) was conducted in Sardinia, one of the world's highest incidence areas for classic Kaposi's sarcoma (KS), Prevalence of antibodies to HHV-8 sVCA was greatest in patients with KS (95%), followed by family members (39%) and a Sardinian control population age-and sex-matched to the relatives (11%). Within families, prevalence of antibodies was about equal among spouses, children, and siblings of KS patients, a finding that raises the possibilities of intrafamilial person-to-person or vertical transmission. Antibodies were detected 2-3 times more frequently in males than in females, The data show that prevalence of antibodies to HHV-8 sVCA correlates with the distribution of classic KS in a high-incidence area, Clustering of seroprevalence within some families suggests the presence of familial risk factors for active HHV-8 infection.
引用
收藏
页码:1715 / 1718
页数:4
相关论文
共 16 条
[1]  
BOSHOFF C, 1995, LANCET, V345, P1043
[2]   HLA AND KAPOSIS-SARCOMA IN SOLID ORGAN-TRANSPLANTATION [J].
BRUNSON, ME ;
BALAKRISHNAN, K ;
PENN, I .
HUMAN IMMUNOLOGY, 1990, 29 (01) :56-63
[3]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[4]   Classical Kaposi's sarcoma in north-east Sardinia: An overview from 1977 to 1991 [J].
Cottoni, F ;
DeMarco, R ;
Montesu, MA .
BRITISH JOURNAL OF CANCER, 1996, 73 (09) :1132-1133
[5]  
Cottoni F, 1996, ACTA DERM-VENEREOL, V76, P59
[6]   EPIDEMIOLOGY OF KAPOSIS SARCOMA IN SWEDEN PRIOR TO THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
DICTOR, M ;
ATTEWELL, R .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :346-351
[7]   Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population [J].
Franceschi, S ;
Geddes, M .
TUMORI, 1995, 81 (05) :308-314
[8]   KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma [J].
Gao, SJ ;
Kingsley, L ;
Li, M ;
Zheng, W ;
Parravicini, C ;
Ziegler, J ;
Newton, R ;
Rinaldo, CR ;
Saah, A ;
Phair, J ;
Detels, R ;
Chang, Y ;
Moore, PS .
NATURE MEDICINE, 1996, 2 (08) :925-928
[9]   Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma [J].
Gao, SJ ;
Kingsley, L ;
Hoover, DR ;
Spira, TJ ;
Rinaldo, CR ;
Saah, A ;
Phair, J ;
Detels, R ;
Parry, P ;
Chang, Y ;
Moore, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (04) :233-241
[10]   KAPOSI-SARCOMA IN ENGLAND AND WALES BEFORE THE AIDS EPIDEMIC [J].
GRULICH, AE ;
BERAL, V ;
SWERDLOW, AJ .
BRITISH JOURNAL OF CANCER, 1992, 66 (06) :1135-1137